Clinical trial · Interventional
ICG-NIR Guided Lymph Node Dissection in Gastric Cancer
Oncologic Safety of Sentinel Lymph Node-guided Lymph Node Dissection Using ICG-NIR Laparoscopy in Gastric Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
As the survival rate of patients with gastric cancer has increased, there has been a growing interest in interventions that improve postoperative quality of life. Therefore minimally invasive surgery or endoscopic resection has been performed much more frequently. However, adequate lymph node dissection is important as well. The aim of the study is to identify the feasibility of indocyanine green - near infra-red (ICG-NIR) guided sentinel lymph node dissection for the treatment of gastric cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stomach Neoplasm | Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ICG-NIR guided surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- ICG injection
- description
- ICG 0.5mg/ml x 0.5ml x 4 sites
- interventionNames
- Procedure: ICG-NIR guided surgery
Primary outcomes (1)
- measure
- sensitivity and specificity
- timeFrame
- 1 month
- description
- sensitivity and specificity of ICG-NIR guided lymph node dissection
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * dignosed gastric adenocarcinoma * tumor: size 4cm or smaller * depth of invasion: mucosa, submucosa, proper muscle * candidates of laparoscopic radical gastrectomy * informed consent Exclusion Criteria: * metachronous malignancy * number of tumors: 2 or more * remnant gastric cancer * indication for endoscopic resection * history of chemotherapy or radiation therapy * pregnancy * allergy to ICG * metastatic gastric cancer
References
Publications (0)
Data not yet available